Posterior Reversible Encephalopathy Syndrome During Acute Lymphoblastic Leukemia Treatment | Zendy

Sıla Atamyıldız | Zendy; Eda Ataseven | Zendy; Cenk Eraslan | Zendy; Mehmet Kantar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Posterior Reversible Encephalopathy Syndrome During Acute Lymphoblastic Leukemia Treatment

Author(s) -

Sıla Atamyıldız,

Eda Ataseven,

Cenk Eraslan,

Mehmet Kantar

Publication year - 2021

Publication title -

the anatolian journal of general medical research

Language(s) - English

Resource type - Journals

eISSN - 1305-7146

pISSN - 1305-7073

DOI - 10.5222/terh.2021.36037

Subject(s) - posterior reversible encephalopathy syndrome , medicine , nausea , vomiting , lymphoblastic leukemia , pediatrics , encephalopathy , altered mental status , anesthesia , leukemia , magnetic resonance imaging , radiology

Posterior reversible encephalopathy syndrome (PRES) is a clinical and radiological syndrome, characterized by acute onset of headache, altered mental status, visual impairment, nausea, vomiting, seizure, and hypertension. PRES is a reversible condition if it is recognized early, but neurological damage or even death may occur. Herein, we present two cases of ALL who developed PRES during their induction therapy and a literature review of PRES.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research